Guidelines for drug treatment of epilepsy: a critical review
Open Access
- 1 September 2008
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 66 (3a) , 591-599
Abstract
This article critically reviews the role of evidence-based medicine and its guidelines, from their logistic preparation to their interpretation. The strengths and weaknesses of the methodological points are presented, as well the reasons for the extreme popularity of the guidelines in developed countries. The review discusses the main foundations of the most cited guidelines and some recent large studies. Some of the final conclusions are that clinical experience is always an important factor to consider, even in the face of solid evidence, to achieve the best possible management of any particular patient.Keywords
This publication has 16 references indexed in Scilit:
- Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review): [RETIRED]Neurology, 2007
- Reassessment: Neuroimaging in the emergency patient presenting with seizure (an evidence-based review)Neurology, 2007
- Evidence‐based Epileptology, Randomized Controlled Trials, and SANAD: A Critical Clinical ViewEpilepsia, 2007
- Choosing a First Drug Treatment for Epilepsy after SANAD: Randomized Controlled Trials, Systematic Reviews, Guidelines and Treating Patients.Epilepsia, 2007
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- What to do When there is no Evidence2007
- ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and SyndromesEpilepsia, 2006
- Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy [RETIRED]Neurology, 2004
- Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED]Neurology, 2004